Allergy & Asthma Network Partners with American College of Allergy, Asthma … – SYS-CON Media (press release)

Allergy & Asthma Network Partners with American College of Allergy, Asthma
SYS-CON Media (press release)
ATLANTA, Oct. 27, 2014 /PRNewswire-USNewswire/ — Allergy & Asthma Network, the leading national nonprofit patient education organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions, and the …

and more »

View full post on asthma – Google News

ResearchMoz: Asthma Therapeutics Market to 2019 – Breakthrough Biologics to … – SYS-CON Media (press release)

ResearchMoz: Asthma Therapeutics Market to 2019 – Breakthrough Biologics to
SYS-CON Media (press release)
A leading business intelligence provider, has released its latest research report "Asthma Market to 2019". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012
Asthma Therapeutics Market Analysis and 2019 ForecastsSBWire (press release)

all 3 news articles »

View full post on asthma – Google News

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 – SYS-CON Media (press release)

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
SYS-CON Media (press release)
The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical

and more »

View full post on asthma – Google News

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for … – SYS-CON Media (press release)

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for
SYS-CON Media (press release)
Montelukast is FDA-approved for treatment of asthma and allergic rhinitis. It works by inhibiting leukotrienes, the chemicals that cause inflammation. Montelukast is considered a second line of defense against asthma or allergic rhinitis.

View full post on asthma – Google News